Top searches

PL

Resources

B2RLaw advises biotech company Ambulero on fundraising

27/01/2021

B2RLaw has advised Ambulero, Inc., a biotechnology company developing cell and gene therapy treatments for patients suffering from vascular disease on funding of up to USD 5.5 million received from from Orphinic Scientific.

As part of the investment, and with the help of B2RLaw, Ambulero and Orphinic formed a Polish subsidiary (Ambulero Sp. z o.o.) that will lead clinical testing of a novel gene therapy for a serious vascular disease in Europe. The disease is rare in the US but more common in certain parts of Central and Eastern Europe.

Ambulero is a biotechnology company dedicated to advancing a platform of cell and gene therapies to treat serious vascular diseases. The company is a 2019 spin-out of the University of Miami co-founded by Robert L. Buchanan, Randy Berholtz, Omaida C. Velazquez and Jun Zhao-Liu. It holds an exclusive license from the University of Miami to develop and commercialize research from the laboratories of Drs. Omaida C. Velazquez and Jun Zhao-Liu.

With offices in Palo Alto, California and Warsaw, Poland, Orphinic Scientific is an innovative drug development and investment company focused on mid-market opportunities and orphan drugs in late preclinical research and Phase 1 or 2.

B2RLaw’s team was led by Partner Szymon Syp and included Senior Associate Iga Wojtczak – Opala and Junior Associate Jakub Niemiec.

Szymon Syp advises, “We congratulate Ambulero and Orphinic Scientific on this transaction. Ambulero’s important work means that people that suffer from serious vascular disease (which at best, causes severe discomfort and at worst, can result in death) can live in comfort with the knowledge that innovative treatment is on the horizon. We wish Ambulero the best of luck on its future clinical testing”.

View more resources

Catch up on the very latest B2RLAW
announcements and news here.

27/03/2024

B2RLaw recommended in the Legal 500 EMEA ranking 2024

We are proud to announce that in this year’s edition of The Legal 500 we have been recommended in 8 categories […]

MORE
26/03/2024

Andrzej Zając speaks at “Poland’s Energy Evolution: Understanding EU Regulations”

Today Andrzej Zając (Advocate, Partner, Head of Real Estate & Energy) was the speaker at “Poland’s Energy Evolution: Understanding EU Regulations” webinar. Andrzej […]

MORE
21/03/2024

Danyila Zubach at Ukrainian Private Equity & Venture Capital Summit

Today you can meet Danyila Zubach (UA Advocate, Junior Associate) at “Ukrainian Private Equity & Venture Capital Summit”. This is the EU-Ukraine […]

MORE
19/03/2024

Record High Damages for LGBTQ+ Victim

B2RLaw actively encourages all its lawyers to partake in ProBono work. We are pleased to share news about this successful […]

MORE
19/03/2024

Pre-Moot session at B2RLaw’s Warsaw office!

Practice makes perfect! University of Warsaw Willem C. Vis Moot Team in a clash with Vis Moot Team Vilnius during a Pre-Moot session at […]

MORE
15/03/2024

Bartłomiej Jankowski recommended in the Chambers & Partners ranking 2024

We are proud to announce that in this year’s edition of Chambers & Partners Europe Guide 2024 our Senior Partner […]

MORE

Get in touch

Not sure who to contact? Let us help you find the right lawyer.

This site uses cookies to improve your experience More information.

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close